Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 13
538
Views
9
CrossRef citations to date
0
Altmetric
Articles

A novel and efficient asymmetric synthesis of anti-HIV drug maraviroc

, , , &
Pages 1721-1728 | Received 01 Feb 2019, Published online: 03 May 2019

References

  • Tanushree, M.; Gaurav, C.; Goutam, R.; Murthy, R. S. R.; Amit, K. G. “Fusion and Binding Inhibition” Key Target for HIV-1 Treatment and Pre-Exposure Prophylaxis: Targets, Drug Delivery and Nanotechnology Approaches. Drug Deliv. 2017, 24, 608–621.
  • Shuvam, C.; Julian, A. S.; Jerome, D. Innovation and Trends in the Development and Approval of Antiviral Medicines: 1987–2017 and Beyond. Antivir Res. 2018, 155, 76–88. DOI: 10.1016/j.antiviral.2018.05.005.
  • Cormier, E. G.; Persuh, M.; Thompson, D. A. D.; Lin, S. W.; Sakmar, T. P.; Olson, W. C.; Dragic, T. Specific Interaction of CCR5 Amino-Terminal Domain Peptides Containing Sulfotyrosines with HIV-1 Envelope Glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 2000, 97, 5762–5767. DOI: 10.1073/pnas.97.11.5762.
  • Sartori, G.; Maggi, R. Use of Solid Catalysts in Friedel-Crafts Acylation Reactions. Chem. Rev. 2006, 106, 1077. DOI: 10.1021/cr040695c.
  • Price, D. A.; Gayton, S.; Selby, M. D.; Ahman, J.; Haycock-Lewandowski, S.; Stammen, B. L.; Warren, A. Initial Synthesis of UK-427,857 (Maraviroc). Tetrahedron Lett. 2005, 46, 5005–5007. DOI: 10.1016/j.tetlet.2005.05.082.
  • Haycock-Lewandowski, S. J.; Wilder, A.; Ahman, J. Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist. Org. Process Res. Dev. 2008, 12, 1094–1103. DOI: 10.1021/op8000614.
  • Åhman, J.; Birch, M.; Haycock-Lewandowski, S. J.; Long, J.; Wilder, A. Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist. Org. Process Res. Dev. 2008, 12, 1104–1113. DOI: 10.1021/op800062d.
  • Price, D. A.; Gayton, S.; Selby, M. D.; Ahman, J.; Haycock-Lewandowski, S. A Practical Synthesis of Piperidine-/Tropane-Substituted 1,2,4-Triazoles. Synlett 2005, 7, 1133–1134. DOI: 10.1055/s-2005-865208.
  • Lou, S.; Moquist, P. N.; Schaus, S. E. Asymmetric Allylboration of Acyl Imines Catalyzed by Chiral Diols. J. Am. Chem. Soc. 2007, 129, 15398–15404. DOI: 10.1021/ja075204v.
  • Zhao, G. L.; Lin, S.; Korotvicka, A.; Deiana, L.; Kullberg, M.; Córdova, A. Asymmetric Synthesis of Maraviroc (UK-427,857). Adv. Synth. Catal. 2010, 352, 2291–2298. DOI: 10.1002/adsc.201000287.
  • Bedell, T. A.; Hone, G. A. B.; Bois, J. D.; Sorensen, E. J. An Expedient Synthesis of Maraviroc (UK-427,857) via C–H functionalization. Tetrahedron Lett. 2015, 56, 3620–3623. DOI: 10.1016/j.tetlet.2015.01.074.
  • Cogan, D. A.; Liu, G.; Kim, K.; Backes, B. J.; Ellman, J. A. Catalytic Asymmetric Oxidation of tert -Butyl Disulfide. Synthesis of tert -Butanesulfinamides, tert -Butyl Sulfoxides, and tert -Butanesulfinimines. J. Am. Chem. Soc. 1998, 120, 8011–8019. DOI: 10.1021/ja9809206.
  • Robak, M. T.; Herbage, M. A.; Ellman, J. A. Synthesis and Applications of Tert-Butanesulfinamide. Chem. Rev. 2010, 110, 3600–3740. DOI: 10.1021/cr900382t.
  • Xu, H. C.; Chowdhury, S.; Ellman, J. A. Asymmetric Synthesis of Amines Using Tert-Butanesulfinamide. Nat. Protoc. 2013, 8, 2271–2280. DOI: 10.1038/nprot.2013.134.
  • Zhu, Y. J.; Liu, Z. R.; Li, H. Y.; Zhou, W. C.; Ye, D. Y. A Novel and Practical Asymmetric Synthesis of Dapoxetine Hydrochloride. Beilstein J. Org. Chem. 2015, 11, 2641–2645. DOI: 10.3762/bjoc.11.283.
  • Liu, Z. J.; Liu, J. T. Asymmetric Synthesis of Either Diastereomer of Trifluoromethylated Allylic Amines by the Selective Reduction of Trifluoromethyl α,β-Unsaturated N-tert-Butanesulfinyl Ketoimines. Chem. Commun. 2008, 41, 5233–5235. DOI: 10.1039/b810459j.
  • Manoussos, P.; Anthony, P. D.; Christa, S. B. L.; Anthony, W. Tropane Derivatives Useful in Therapy. U.S. Patent US7217721B2, May 15, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.